BRCA1 MUTATION
Clinical trials for BRCA1 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRCA1 MUTATION trials appear
Sign up with your email to follow new studies for BRCA1 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for BRCA breast cancer patients
Disease control CompletedThis early-phase trial tested a combination of three drugs (olaparib, palbociclib, and fulvestrant) in 9 adults with BRCA-mutated, hormone receptor-positive, HER2-negative breast cancer that had spread or could not be removed. The main goal was to see if the combination was safe …
Matched conditions: BRCA1 MUTATION
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
Toolkit may help families discuss cancer gene risks
Knowledge-focused CompletedThis study looked at whether a special toolkit helps people with BRCA gene mutations tell their relatives about their genetic test results. The goal was to see if the toolkit makes it easier to share this information and if more at-risk family members then decide to get tested th…
Matched conditions: BRCA1 MUTATION
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC